HCAT Health Catalyst, Inc.
Services-Computer Programming, Data Processing, Etc. · Nasdaq · SEC CIK 1636422 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-13.9%
TTM net income YoY-87.8%
TTM EPS YoY-77.2%
Revenue 3-yr CAGR-2.1%
Net income 3-yr CAGR—
Margins
Gross margin49.1%
Operating margin-65.7%
Net margin-74.2%
FCF margin9.4%
EBITDA margin-48.9%
Returns
ROE-84.6%
ROA-49.0%
ROIC (approx.)-52.7%
Asset turnover0.66x
Leverage & solvency
Liabilities / assets38.7%
Debt / equity0.00x
Current ratio1.70x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.13x
Accruals ratio-55.5%
Payout ratio—
Capex / revenue0.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $56.28M | $70.49M | $70.76M | $74.68M | $76.32M | $80.72M | $79.41M | $79.61M |
| Cost of revenue | $32.24M | $35.63M | $35.29M | $35.30M | $38.51M | $42.48M | $43.18M | $44.91M |
| Gross profit | $24.04M | $34.86M | $35.46M | $39.38M | $40.13M | $38.24M | $36.23M | $34.69M |
| R&D expense | $9.50M | $11.03M | $9.78M | $9.91M | $12.28M | $12.39M | $15.19M | $15.00M |
| SG&A expense | $12.00M | $11.93M | $13.96M | $11.04M | $16.07M | $8.28M | $14.16M | $15.68M |
| Operating income | $50.14M | -$36.48M | -$106.48M | -$86.08M | -$17.51M | -$37.09M | -$20.17M | -$17.50M |
| Income tax | -$393,000 | $315,000 | $414,000 | $379,000 | $41,000 | $81,000 | $215,000 | $625,000 |
| Net income | $40.50M | -$40.54M | -$111.03M | -$91.03M | -$22.23M | -$40.98M | -$23.74M | -$20.67M |
| EBITDA | $59.87M | -$25.50M | -$94.36M | -$73.20M | -$4.89M | -$24.41M | -$7.85M | -$7.23M |
| EPS (basic) | 0.54 | -0.55 | -1.53 | — | -0.32 | -0.59 | -0.35 | — |
| EPS (diluted) | 0.53 | -0.55 | -1.53 | — | -0.32 | -0.59 | -0.35 | — |
| Weighted avg. shares (diluted) | 75.93M | 73.96M | 72.59M | — | 70.38M | 69.63M | 68.55M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $53.75M | $60.59M | $59.86M | $50.81M | $40.30M | $50.71M | $341.97M | $249.65M |
| Short-term investments | $25.25M | $42.85M | $48.96M | $44.92M | $51.23M | $46.63M | $0 | $142.35M |
| Receivables | $41.33M | $41.90M | $59.15M | $59.13M | $60.11M | $68.38M | $64.05M | $57.18M |
| Current assets | $132.97M | $248.39M | $182.31M | $169.31M | $165.35M | $180.58M | $422.72M | $465.65M |
| PP&E, net | $34.46M | $33.47M | $34.94M | $33.84M | $32.61M | $33.40M | $31.65M | $29.39M |
| Goodwill | $11.10M | $11.10M | $113.25M | $209.07M | $285.59M | $286.10M | $313.38M | $259.76M |
| Intangibles | $50.08M | $56.12M | $69.33M | $77.68M | $89.55M | $98.35M | $106.40M | $86.05M |
| Total assets | $237.42M | $358.60M | $412.20M | $502.64M | $587.13M | $616.18M | $891.54M | $858.93M |
| Current liabilities | $78.15M | $91.92M | $107.61M | $89.57M | $87.89M | $98.82M | $339.56M | $325.85M |
| Short-term debt | $0 | $1.63M | $1.63M | $1.63M | $1.63M | $1.63M | $231.56M | $231.18M |
| Long-term debt | $0 | $151.85M | $151.74M | $151.62M | $151.51M | $151.40M | $151.29M | $151.18M |
| Total debt | $0 | $153.48M | $153.37M | $153.25M | $153.14M | $153.03M | $382.85M | $382.36M |
| Total liabilities | $91.83M | $257.78M | $274.06M | $256.86M | $255.21M | $268.63M | $514.73M | $493.72M |
| Shareholders' equity | $145.59M | $100.83M | $138.15M | $245.78M | $331.92M | $347.55M | $376.81M | $365.21M |
| Net debt | -$53.75M | $92.89M | $93.50M | $102.44M | $112.83M | $102.32M | $40.89M | $132.72M |
| Shares outstanding | 76.16M | 74.60M | 73.75M | 72.03M | 70.62M | 70.27M | 69.48M | 64.04M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.88M | $275,000 | $18.51M | $9.91M | -$464,000 | -$9.00M | $280,000 | -$3.53M |
| Capital expenditure | $156,000 | $345,000 | $338,000 | $273,000 | $255,000 | -$230,000 | $670,000 | $413,000 |
| Free cash flow | -$2.03M | -$70,000 | $18.17M | $9.64M | -$719,000 | -$8.77M | -$390,000 | -$3.94M |
| Investing cash flow | $157.89M | $902,000 | -$9.41M | $1.01M | -$9.35M | -$52.23M | $96.76M | -$112.75M |
| Financing cash flow | -$162.88M | -$450,000 | -$4,000 | -$434,000 | -$537,000 | -$230.10M | -$4.71M | $37.69M |
| Depreciation & amortization | $9.73M | $10.98M | $12.12M | $12.88M | $12.61M | $12.68M | $12.32M | $10.27M |
| Stock-based compensation | $4.08M | $2.71M | $3.77M | $4.11M | $7.04M | $8.32M | $7.54M | $10.81M |
| Share buybacks | $0 | $0 | $0 | $0 | $0 | $0 | $5.00M | $0 |
Free plan shows the latest 8 periods; Pro shows all 34 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.